<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

The Cancer Letter

Race For The Cure Grants For National Capital Area.

Two Drugs Slow Progress Of Metastatic Prostate Cancer

AACR Grant Programs. NIH RFA Available.

New Ultrasound Technique For Hard To Diagnose Cysts

Program Announcements. RAPID Program Date Change.

NCI-Approved Clinical Trials Listed For May 2001

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

Celgene Begins Two Studies With Hoffmann-La Roche.

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.